European Journal of Pharmacology 1994: Vol 265 Index

7 Pages·1994·1.4 MB·English

European Journal of Pharmacology 265 (1994) 189-190
Author index
Agabio, R., see Colombo, G. (265) 167 Gardier, A.M., Trillat, A.-C., Malagié, |. and Jacquot, C.
Artigas, F., see Romero, L. (265) 103 8-OH-DPAT attenuates the dexfenfluramine-induced increase in
Audinot, V., see Rivet, J.-M. (265) 175 extracellular serotonin: an in vivo dialysis study (265) 107
Gavin, K., see Browne, I. (265) 125
Bara, A., see Schini-Kerth, V. (265) 83 Gessa, G.L., see Colombo, G. (265) 167
Battaini, F., see Pascale, A. (265) 1 Ghiani, C.A., see Serra, M. (265) 185
Beani, L., see Simonato, M. (265) 121 Gies, J.-P., see Lach, E. (265) 117
Belcourt, A., see Greney, H. (265) R1 Gobert, A., see Rivet, J.-M. (265) 175
Bengen, J., see Galle, J. (265) 111 Govoni, S., see Pascale, A. (265) 1
Bennai, F., see Greney, H. (265) R1 Greney, H., Bennai, F., Molines, A., Belcourt, A., Dontenwill, M.
Bianchi, C., see Simonato, M. (265) 121 and Bousquet, P.
Biggio, G., see Serra, M. (265) 185 Isolation of a human cerebral imidazoline-specific binding pro-
Bolognesi, M.L., see Melchiorre, C. (265) 93 tein (265) R1
Borea, P.A., see Simonato, M. (265) 121 Guh, J.-H., see Teng, C.-M. (265) 61
Bousquet, P., see Greney, H. (265) R1
Bredy-Dobreva, G., see Mizhorkova, Z. (265) 77 Hamel, C., see Contesse, V. (265) 27
Browne, I., Thomas, G., Gavin, K. and Docherty, J.R. Hidaka, K., see Wanibuchi, F. (265) 151
Prejunctional actions of N-ethyl-maleimide and phenoxybenza- Hill, R.G., see Longmore, J. (265) 53
mine in rat vas deferens (265) 125 Hogg, J.E., see Longmore, J. (265) 53
Busse, R., see Schini-Kerth, V. (265) 83 Hong, S.J. and Chang, C.C.
Facilitation of nicotinic receptor desensitization at mouse motor
Carnuccio, R., see luvone, T. (265) 89 endplate by a receptor-operated Ca** channel blocker, SK&F
Celada, P., see Romero, L. (265) 103 96365 (265) 35
Chang, C.C., see Hong, S.J. (265) 35 Howell, R.E., Kovalsky, M.P. and Laemont, K.D.
Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F. and Methoctramine induces nonspecific airway hyperresponsiveness
Gessa, G.L. in vivo (265) 67
Blockade of ethanol discrimination by isradipine (265) 167 Hutson, P.H., see Longmore, J. (265) 53
Connelly, S.T., see Shepard, P.D. (265) 141
Contesse, V., Hamel, C., Delarue, C., Lefebvre, H. and Vaudry, H. luvone, T., Carnuccio, R. and Di Rosa, M.
Effect of a series of 5-HT, receptor agonists and antagonists on Modulation of granuloma formation by endogenous nitric oxide
steroid secretion by the adrenal gland in vitro (265) 27 (265) 89
Corsico, N., see Pascale, A. (265) 1
Jacquot, C., see Gardier, A.M. (265) 107
Coy, D.H., see Lach, E. (265) 117
Crowder, R.E., see McCarthy, H.D. (265) 99
Ko, F.-N., see Teng, C.-M. (265) 61
Kohno, S., see Yamamura, H. (265) 9
Delarue, C., see Contesse, V. (265) 27
Kojima, C., see Satoh, M. (265) 133
Di Rosa, M., see luvone, T. (265) 89
Kokubu, N., see Satoh, M. (265) 133
Docherty, J.R., see Browne, I. (265) 125
Kortezova, N., see Mizhorkova, Z. (265) 77
Donatini, A., see Melchiorre, C. (265) 93
Koshiya, K., see Wanibuchi, F. (265) 151
Dontenwill, M., see Greney, H. (265) R1
Kovalsky, M.P., see Howell, R.E. (265) 67
Dryden, S., see McCarthy, H.D. (265) 99
Kwon, I.-S., see Lutfy, K. (265) 171
Dumont, P., see Lach, E. (265) 117
Lach, E., Coy, D.H., Dumont, P., Landry, Y. and Gies, J.-P.
Eden, R.J., see Parker, $.G. (265) 17 Gastrin releasing peptide-preferring bombesin binding sites in
human lung (265) 117
Fadda, F., see Colombo, G. (265) 167 Laemont, K.D., see Howell, R.E. (265) 67
Ferri, S., see Melchiorre, C. (265) 93 Landry, Y., see Lach, E. (265) 117
Fujimoto, S. Lefebvre, H., see Contesse, V. (265) 27
Effects of pimobendan, its active metabolite UD-CG 212, and Lehmann, H., see Shepard, P.D. (265) 141
milrinone on isolated blood vessels (265) 159 Lobina, C., see Colombo, G. (265) 167
Longmore, J., Hogg, J.E., Hutson, P.H. and Hill, R.G.
Galle, J., Bengen, J., Schollmeyer, P. and Wanner, C. Effects of two truncated forms of human calcitonin-gene related
Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: peptide: implications for receptor classification (265) 53
prevention by high density lipoprotein (265) 111 Lucchi, L., see Pascale, A. (265) 1
190 Author index / European Journal of Pharmacology 265 (1994) 189-190
Lutfy, K., Sadowski, B., Kwon, I.-S. and Weber, E. Schini-Kerth, V., Bara, A., Miilsch, A. and Busse, R.
Morphine analgesia and tolerance in mice selectively bred for Pyrrolidine dithiocarbamate selectively prevents the expression of
divergent swim stress-induced analgesia (265) 171 the inducible nitric oxide synthase in the rat aorta (265) 83
Schollmeyer, P., see Galle, J. (265) 111
Malagié, I., see Gardier, A.M. (265) 107 Schiitz, W., see Todt, H. (265) 43
Martelli, E.A., see Pascale, A. (265) 1 Serra, M., Ghiani, C.A., Spano, S. and Biggio, G.
McCarthy, H.D., Crowder, R.E., Dryden, S. and Williams, G.
Felbamate antagonizes isoniazid- and FG 7142-induced reduction
Megestrol acetate stimulates food and water intake in the rat: of GABA , receptor function in mouse brain (265) 185
effects on regional hypothalamic neuropeptide Y concentrations Shepard, P.D., Lehmann, H. and Connelly, S.T.
(265) 99
Effects of NPC16377, a potent and selective o receptor ligand,
Melchiorre, C., Romualdi, P., Bolognesi, M.L., Donatini, A. and on the activity of mesencephalic dopamine-containing neurons in
Ferri, S. the rat (265) 141
Binding profile of benextramine at neuropeptide Y receptor Simonato, M., Varani, K., Muzzolini, A., Bianchi, C., Beani, L. and
subtypes in rat brain areas (265) 93 Borea, P.A.
Milano, S., see Pascale, A. (265) 1 Adenosine A, receptors in the rat brain in the kindling model of
Millan, M.J., see Rivet, J.-M. (265) 175 epilepsy (265) 121
Mizhorkova, Z., Kortezova, N., Bredy-Dobreva, G. and Papasova, M. Spano, S., see Serra, M. (265) 185
Role of nitric oxide in mediating non-adrenergic non-cholinergic
relaxation of the cat ileocecal sphincter (265) 77
Molines, A., see Greney, H. (265) R1 Takayanagi, I., see Satoh, M. (265) 133
Miilsch, A., see Schini-Kerth, V. (265) 83 Teng, C.-M., Guh, J.-H. and Ko, F.-N.
Muzzolini, A., see Simonato, M. (265) 121 Functional identification of a,-adrenoceptor subtypes in human
prostate: comparison with those in rat vas deferens and spleen
Nabe, T., see Yamamura, H. (265) 9 (265) 61
Nishida, T., see Wanibuchi, F. (265) 151 Thomas, G., see Browne, I. (265) 125
Todt, H., Zojer, N., Raberger, G. and Schiitz, W.
Ohata, K., see Yamamura, H. (265) 9 Prolongation of the QT interval by dofetilide modulates rate-de-
Papasova, M., see Mizhorkova, Z. (265) 77 pendent effects of mexiletine on intraventricular conduction (265)
Parker, S.G., Raval, P., Yeulet, S. and Eden, R_J. 43
Tolerance to peripheral, but not central, effects of ropinirole, a Trabucchi, M., see Pascale, A. (265) 1
selective dopamine D,-like receptor agonist (265) 17 Trillat, A.-C., see Gardier, A.M. (265) 107
Pascale, A., Milano, S., Corsico, N., Lucchi, L., Battaini, F., Martelli, Tsukamoto, S.-i., see Wanibuchi, F. (265) 151
E.A., Trabucchi, M. and Govoni, S.
Protein kinase C activation and anti-amnesic effect of acetyl-.- Usuda, S., see Wanibuchi, F. (265) 151
carnitine: in vitro and in vivo studies (265) 1
Peglion, J.-L., see Rivet, J.-M. (265) 175 Varani, K., see Simonato, M. (265) 121
Raberger, G., see Todt, H. (265) 43 Vaudry, H., see Contesse, V. (265) 27
Raval, P., see Parker, $.G. (265) 17
Reali, R., see Colombo, G. (265) 167 Wanibuchi, F., Nishida, T., Yamashita, H., Hidaka, K., Koshiya, K.,
Rivet, J.-M., Audinot, V., Gobert, A., Peglion, J.-L. and Millan, M.J. Tsukamoto, S.-i. and Usuda, S.
Modulation of mesolimbic dopamine release by the selective Characterization of a novel muscarinic receptor agonist, YM796:
dopamine D, receptor antagonist, (+ )-S 14297 (265) 175 comparison with cholinesterase inhibitors in in vivo pharmacolog-
Romero, L., Celada, P. and Artigas, F. ical studies (265) 151
Reduction of in vivo striatal 5-hydroxytryptamine release by 8- Wanner, C., see Galle, J. (265) 111
OH-DPAT after inactivation of G;/G,, proteins in dorsal raphe Weber, E., see Lutfy, K. (265) 171
nucleus (265) 103 Williams, A.R., see Rupniak, N.M.J. (265) 179
Romualdi, P., see Melchiorre, C. (265) 93 Williams, G., see McCarthy, H.D. (265) 99
Rupniak, N.M.J. and Williams, A.R.
Differential inhibition of foot tapping and chromodacryorrhoea Yamamura, H., Nabe, T., Kohno, S. and Ohata, K.
in gerbils by CNS penetrant and non-penetrant tachykinin NK, Endothelin-1, one of the most potent histamine releasers in
receptor antagonists (265) 179
mouse peritoneal mast cells (265) 9
Sadowski, B., see Lutfy, K. (265) 171 Yamashita, H., see Wanibuchi, F. (265) 151
Satoh, M., Kojima, C., Kokubu, N. and Takayanagi, I. Yeulet, S., see Parker, $.G. (265) 17
a,-Adrenoceptor subtypes mediating the regulation and modula-
tion of Ca?* sensitization in rabbit thoracic aorta (265) 133 Zojer, N., see Todt, H. (265) 43
ELSEVIER
European Journal of Pharmacology 265 (1994) 191-195
Key word index
Accumbens Atrium, guinea-pig
Dopamine D, receptor; Microdialysis (Rivet, J.-M. (265) 175) aCGRP (calcitonin-gene related peptide), human; aCGRP-48-—37),
human; BCGRP-~8-37), human; Vas deferens, rat; SK-N-MC cell
Acetyl-.-carnitine (Longmore, J. (265) 53)
Protein kinase C; Behavior; (Rat) (Pascale, A. (265) 1)
Azabicycloalky! benzimidazolone derivative
Action potential duration 5-HT (5-hydroxytryptamine, serotonin); 5-HT, receptor; Benzamide
Mexiletine; Dofetilide; Conduction; OT duration; (Guinea-pig), (In derivative; GR 113808; Adrenal gland (Contesse, V. (265) 27)
vivo) (Todt, H. (265) 43)
Behavior
Adenosine Acetyl-.-carnitine; Protein kinase C; (Rat) (Pascale, A. (265) 1)
Epilepsy; Kindling; Glutamate binding; Glutamate release (Simonato,
M. (265) 121) Benextramine
Neuropeptide Y; Nonpeptide antagonist; Neuropeptide Y receptor
Adrenal gland subtype; Binding affinity (Melchiorre, C. (265) 93)
5-HT (5-hydroxytryptamine, serotonin), 5-HT, receptor; Benzamide
derivative; Azabicycloalky! benzimidazolone derivative; GR 113808 Benzamide derivative
(Contesse, V. (265) 27) 5-HT (5-hydroxytryptamine, serotonin); 5-HT, receptor; Aza-
icycloalky!l benzimidazolone derivative; GR 113808; Adrenal gland
a ,-Adrenoceptor (Contesse, V. (265) 27)
Thoracic aorta; B-Escin-skinned fiber; Myosin light chain phospho-
rylation (Satoh, M. (265) 133) Binding affinity
Neuropeptide Y; Benextramine; Nonpeptide antagonist; Neuropep-
a ,-Adrenoceptor tide Y receptor subtype (Melchiorre, C. (265) 93)
Vas deferens, rat; N-Ethyl-maleimide; Phenoxybenzamine; EEDQ
( N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline) (Browne, 1. (265) Blood vessel
125) Phosphodiesterase inhibitor; Pimobendan; Milrinone; UD-CG 212
(Fujimoto, S. (265) 159)
a ,-Adrenoceptor subtype
Chloroethyiclonidine; Nifedipine; Vas deferens, rat; Spleen, rat; Bombesin
Prostate, human (Teng, C.-M. (265) 61) GRP (gastrin-releasing peptide); Bombesin binding site; Lung, hu-
man; GRP-preferring bombesin receptor (Lach, E. (265) 117)
Allergy and immunology
Muscarinic receptor; Smooth muscle, airway; Bronchodilator agent; Bombesin binding site
(Guinea pig) (Howell, R.E. (265) 67) Bombesin; GRP (gastrin-releasing peptide), Lung, human; GRP-pre-
ferring bombesin receptor (Lach, E. (265) 117)
d-Amphetamine
Dopamine; Electrophysiology; Receptor; Antipsychotic; (Rat) Brain, human
(Shepard, P.D. (265) 141) Imidazoline; Clonidine (Greney, H. (265) R1)
Analgesia Bronchodilator agent
Morphine; Selective breeding; Tail flick assay; Tolerance (Lutfy, K. Muscarinic receptor; Smooth muscle, airway; Allergy and immunol-
(265) 171) ogy: (Guinea pig) (Howell, R.E. (265) 67)
Antipsychotic L-type Ca?* channel
Dopamine; Electrophysiology, Receptor; d-Amphetamine; (Rat) Ethanol; Isradipine; Drug discrimination; (Rat) (Colombo, G. (265)
(Shepard, P.D. (265) 141) 167)
Appetite Cachexia
Neuropeptide Y; Megestrol acetate; Cancer anorexia; Cachexia; Neuropeptide Y; Megestrol acetate; Appetite; Cancer anorexia; Hy-
Hypothalamus (McCarthy, H.D. (265) 99) pothalamus (McCarthy, H.D. (265) 99)
L-Arginine Cancer anorexia
Granuloma; Nitric oxide (NO); N°-Nitro-1-arginine methyl ester; Neuropeptide Y; Megestrol acetate; Appetite; Cachexia; Hypothala-
Macrophage (luvone, T. (265) 89) mus (McCarthy, H.D. (265) 99)
192 Key word index / European Journal of Pharmacology 265 (1994) 191-195
Cardiovascular Dopamine D, receptor
Ropinirole; Dopamine; D,-like receptor; Spontaneously hypertensive Microdialysis; Accumbens (Rivet, J.-M. (265) 175)
rat (SHR); Tolerance; (Monkey) (Parker, S.G. (265) 17)
Dorsal raphe nucleus
aCGRP (calcitonin-gene related peptide), human G-protein; 5-HT,, receptor; 5-HT (S-hydroxytryptamine, serotonin)
aCGRP-~8-37), human; BCGRP-~8-37), human; Vas deferens, rat; release; Microdialysis; Intracerebral; 8-OH-DPAT (8-hydroxy-2-(di-
Atrium, guinea-pig; SK-N-MC cell (Longmore, J. (265) 53) n-propylamino)tetralin) (Romero, L. (265) 103)
aCGRP-(8-37), human Drug discrimination
aCGRP (calcitonin-gene related peptide), human; BCGRP-(8-37), Ethanol; Isradipine; L-type Ca?* channel; (Rat) (Colombo, G. (265)
human; Vas deferens, rat; Atrium, guinea-pig; SK-N-MC cell 167)
(Longmore, J. (265) 53)
EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline )
BCGRP-(8-37), human
Vas deferens, rat; a,-Adrenoceptor; N-Ethyl-maleimide; Phenoxy-
aCGRP (calcitonin-gene related peptide), human; aCGRP-(8-37),
benzamine (Browne, I. (265) 125)
human; Vas deferens, rat; Atrium, guinea-pig; SK-N-MC cell
(Longmore, J. (265) 53)
Electrical field stimulation
Nitric oxide (NO); NANC (non-adrenergic non-cholinergic) transmis-
Chloroethylclonidine
sion; Nicotinic receptor; Ileocecal sphincter; (Cat) (Mizhorkova, Z.
a,-Adrenoceptor subtype; Nifedipine; Vas deferens, rat; Spleen, rat;
(265) 77)
Prostate, human (Teng, C.-M. (265) 61)
Electrophysiology
Chromodacryorrhea
Tachykinin NK, receptor; Foot tapping; CNS (central nervous sys- Dopamine; Receptor; d-Amphetamine; Antipsychotic; (Rat)
(Shepard, P.D. (265) 141)
tem) penetration; (Gerbil) (Rupniak, N.M.J. (265) 179)
Clonidine Endothelin-1
Imidazoline; Brain, human (Greney, H. (265) R1) Mast cell; Histamine; Compound 48/80; Islet-activating protein;
Endothelin receptor (Yamamura, H. (265) 9)
CNS (central nervous system) penetration
Tachykinin NK, receptor; Chromodacryorrhea; Foot tapping; Endothelin receptor
(Gerbil) (Rupniak, N.M.J. (265) 179) Mast cell; Endothelin-1; Histamine; Compound 48 /80; Islet-activat-
ing protein (Yamamura, H. (265) 9)
Compound 48 /80
Mast cell; Endothelin-1; Histamine; Islet-activating protein; En- Endothelium
dothelin receptor (Yamamura, H. (265) 9) Interleukin-18; cGMP; Vascular tone (Schini-Kerth, V. (265) 83)
Conduction Lipoprotein; Vasodilation; Nitric oxide (NO) (Galle, J. (265) 111)
Mexiletine; Dofetilide; Action potential duration; QT duration;
(Guinea-pig); (In vivo) (Todt, H. (265) 43) Endplate potential
SK& F 96365; Neostigmine; Nicotinic acetylcholine receptor; Recep-
Convulsion tor desensitisation (Hong, S.J. (265) 35)
Felbamate; Diazepam; Isoniazid; FG 7142; GABAergic transmission
(Serra, M. (265) 185) Epilepsy
Adenosine; Kindling; Glutamate binding; Glutamate release
Dexfenfluramine
(Simonato, M. (265) 121)
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); 5-HT,, au-
toreceptor; 5-HT (5-hydroxytryptamine, serotonin) release; Frontal
B-Escin-skinned fiber
cortex; Microdialysis (Gardier, A.M. (265) 107)
a,-Adrenoceptor; Thoracic aorta; Myosin light chain phosphoryl-
ation (Satoh, M. (265) 133)
Diazepam
Felbamate; Isoniazid; FG 7142; Convulsion; GABAergic transmis-
Ethanol
sion (Serra, M. (265) 185)
Isradipine; L-type Ca?* channel; Drug discrimination; (Rat) (Col-
D,-like receptor ombo, G. (265) 167)
Ropinirole; Dopamine; Spontaneously hypertensive rat (SHR); Car-
diovascular; Tolerance; (Monkey) (Parker, $.G. (265) 17) N-Ethyl-maleimide
Vas deferens, rat; a,-Adrenoceptor; Phenoxybenzamine; EEDQ
Dofetilide (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline) (Browne, |. (265)
Mexiletine; Conduction; Action potential duration; QT duration; 125)
(Guinea-pig); (In vivo) (Todt, H. (265) 43)
Felbamate
Dopamine Diazepam; Isoniazid; FG 7142; Convulsion; GABAergic transmission
Ropinirole; D,-like receptor; Spontaneously hypertensive rat (SHR); (Serra, M. (265) 185)
Cardiovascular; Tolerance; (Monkey) (Parker, $.G. (265) 17)
FG 7142
Electrophysiology; Receptor; d-Amphetamine; Antipsychotic; (Rat) Felbamate; Diazepam; Isoniazid; Convulsion; GABAergic transmis-
(Shepard, P.D. (265) 141) sion (Serra, M. (265) 185)
Key word index / European Journal of Pharmacology 265 (1994) 191-195
Foot tapping 5-HT, receptor
Tachykinin NK, receptor; Chromodacryorrhea; CNS (central ner- 5-HT (5-hydroxytryptamine, serotonin), Benzamide derivative; Aza-
vous system) penetration; (Gerbil) (Rupniak, N.M.J. (265) 179) bicycloalkyl benzimidazolone derivative; GR 113808; Adrenal gland
(Contesse, V. (265) 27)
Frontal cortex
Dexfenfluramine; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te- 5-HT,, receptor
tralin); 5S-HT,, autoreceptor; 5-HT (5-hydroxytryptamine, serotonin) Dorsal raphe nucleus; G-protein; 5-HT (5-hydroxytryptamine, sero-
release; Microdialysis (Gardier, A.M. (265) 107) tonin) release; Microdialysis; Intracerebral; 8-OH-DPAT (8-hydroxy-
24di-n-propylamino)}tetralin) (Romero, L. (265) 103)
GABAergic transmission
Felbamate; Diazepam; Isoniazid; FG 7142; Convulsion (Serra, M. Hypothalamus
(265) 185) Neuropeptide Y; Megestrol acetate; Appetite; Cancer anorexia;
Cachexia (McCarthy, H.D. (265) 99)
Glutamate binding
Adenosine; Epilepsy; Kindling; Glutamate release (Simonato, M. lleocecal sphincter
(265) 121) Nitric oxide (NO); NANC (non-adrenergic non-cholinergic) transmis-
sion; Electrical field stimulation; Nicotinic receptor; (Cat)
Glutamate release (Mizhorkova, Z. (265) 77)
Adenosine; Epilepsy; Kindling; Glutamate binding (Simonato, M.
(265) 121) imidazoline
Clonidine; Brain, human (Greney, H. (265) R1)
cGMP
Interleukin-18; Endothelium; Vascular tone (Schini-Kerth, V. (265) Interleukin-18
83) Endothelium; cGMP; Vascular tone (Schini-Kerth, V. (265) 83)
G-protein Intracerebral
Dorsal raphe nucleus; 5-HT,, receptor; 5-HT (5-hydroxytryptamine, Dorsal raphe nucleus; G-protein; 5-HT,, receptor; 5-HT (5-hydroxy-
serotonin) release; Microdialysis; Intracerebral; 8-OH-DPAT (8-hy- tryptamine, serotonin) release; Microdialysis; 8-OH-DPAT (8-hy-
droxy-2-(di-n-propylamino)tetralin) (Romero, L. (265) 103) droxy-2-(di-n-propylamino)tetralin) (Romero, L. (265) 103)
GR 113808 Islet-activating protein
5-HT (S-hydroxytryptamine, serotonin); 5-HT, receptor; Benzamide Mast cell; Endothelin-1; Histamine; Compound 48/80; Endothelin
derivative; Azabicycloalkyl benzimidazolone derivative; Adrenal receptor (Yamamura, H. (265) 9)
gland (Contesse, V. (265) 27)
Isoniazid
Granuloma Felbamate; Diazepam; FG 7142; Convulsion; GABAergic transmis-
Nitric oxide (NO); L-Arginine; N©-Nitro-.-arginine methyl ester; sion (Serra, M. (265) 185)
Macrophage (Iuvone, T. (265) 89)
Isradipine
GRP (gastrin-releasing peptide) Ethanol; L-type Ca** channel; Drug discrimination; (Rat) (Col-
Bombesin; Bombesin binding site; Lung, human; GRP-preferring ombo, G. (265) 167)
bombesin receptor (Lach, E. (265) 117)
Kindling
GRP-preferring bombesin receptor Adenosine; Epilepsy; Glutamate binding; Glutamate release
Bombesin; GRP (gastrin-releasing peptide); Bombesin binding site; (Simonato, M. (265) 121)
Lung, human (Lach, E. (265) 117)
Learning behavior
Histamine Muscarinic acetylcholine receptor agonist; YM796; Muscarinic M,
Mast cell; Endothelin-1; Compound 48 /80; Islet-activating protein; receptor; Muscarinic M, receptor (Wanibuchi, F. (265) 151)
Endothelin receptor (Yamamura, H. (265) 9)
Lipoprotein
5-HT,, autoreceptor Vasodilation; Nitric oxide (NO), Endothelium (Galle, J. (265) 111)
Dexfenfluramine; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te-
tralin); 5-HT (5-hydroxytryptamine, serotonin) release; Frontal cor- Lung, human
tex; Microdialysis (Gardier, A.M. (265) 107) Bombesin; GRP (gastrin-releasing peptide); Bombesin binding site;
GRP-preferring bombesin receptor (Lach, E. (265) 117)
5-HT (5-hydroxytryptamine, serotonin)
5-HT, receptor; Benzamide derivative; Azabicycloalkyl benzimida- Macrophage ;
zolone derivative; GR 113808; Adrenal gland (Contesse, V. (265) 27) Granuloma; Nitric oxide (NO); t-Arginine; N©-Nitro-1-arginine
methyl ester (luvone, T. (265) 89)
5-HT (5-hydroxytryptamine, serotonin) release
Dorsal raphe nucleus; G-protein; 5-HT,, receptor; Microdialysis; Mast cell
Intracerebral; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin) Endothelin-1; Histamine; Compound 48 /80,; Islet-activating protein;
(Romero, L. (265) 103) Endothelin receptor (Yamamura, H. (265) 9)
Dexfenfluramine; 8-OH-DPAT (8-hydroxy-2-di-n-propylamino)te- Megestrol acetate
tralin); 5-HT,, autoreceptor; Frontal cortex; Microdialysis (Gardier, Neuropeptide Y; Appetite; Cancer anorexia; Cachexia; Hypothala-
A.M. (265) 107) mus (McCarthy, H.D. (265) 99)
194 Key word index / European Journal of Pharmacology 265 (1994) 191-195
Mexiletine Nicotinic receptor
Dofetilide; Conduction; Action potential duration; QT duration; Nitric oxide (NO); NANC (non-adrenergic non-cholinergic) transmis-
(Guinea-pig); (In vivo) (Todt, H. (265) 43) sion; Electrical field stimulation; Ileocecal sphincter; (Cat)
(Mizhorkova, Z. (265) 77)
Microdialysis
Dorsal raphe nucleus; G-protein; 5-HT,, receptor; 5-HT (S-hydroxy- Nifedipine
tryptamine, serotonin) release; Intracerebral; 8-OH-DPAT (8-hy- a,-Adrenoceptor subtype; Chloroethylclonidine; Vas deferens, rat;
droxy-2-(di-n-propylamino)tetralin) (Romero, L. (265) 103) Spleen, rat; Prostate, human (Teng, C.-M. (265) 61)
Dexfenfluramine; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)te- Nitric oxide (NO)
tralin); 5-HT,, autoreceptor; 5-HT (S-hydroxytryptamine, serotonin) NANC (non-adrenergic non-cholinergic) transmission; Electrical
release; Frontal cortex (Gardier, A.M. (265) 107) field stimulation; Nicotinic receptor; Ileocecal sphincter; (Cat)
(Mizhorkova, Z. (265) 77)
Dopamine D, receptor; Accumbens (Rivet, J.-M. (265) 175)
Granuloma; L-Arginine; N°-Nitro-.-arginine methyl ester; Macro-
Milrinone phage (Iuvone, T. (265) 89)
Blood vessel; Phosphodiesterase inhibitor; Pimobendan; UD-CG 212
(Fujimoto, S. (265) 159) Lipoprotein; Vasodilation; Endothelium (Galle, J. (265) 111)
N®.Nitro-t-arginine methyl ester
Morphine
Analgesia; Selective breeding; Tail flick assay; Tolerance (Lutfy, K. Granuloma; Nitric oxide (NO); L-Arginine; Macrophage (luvone, T.
(265) 89)
(265) 171)
Muscarinic acetylcholine receptor agonist Nonpeptide antagonist
YM796; Muscarinic M, receptor; Muscarinic M, receptor; Learning Neuropeptide Y; Benextramine; Neuropeptide Y receptor subtype;
behavior (Wanibuchi, F. (265) 151) Binding affinity (Melchiorre, C. (265) 93)
8-OH-DPAT (8-hydroxy-2-(di-n-propy)ltaetmrialnion)
Muscarinic receptor
Dorsal raphe nucleus; G-protein; 5-HT,, receptor; 5-HT (5-hydroxy-
Smooth muscle, airway; Bronchodilator agent; Allergy and immunol-
tryptamine, serotonin) release; Microdialysis; Intracerebral (Romero,
ogy; (Guinea pig) (Howell, R.E. (265) 67)
L. (265) 103)
Muscarinic M, receptor
Dexfenfluramine; 5-HT,, autoreceptor; 5-HT (5-hydroxytryptamine,
Muscarinic acetylcholine receptor agonist; YM796; Muscarinic M,
serotonin) release; Frontal cortex; Microdialysis (Gardier, A.M. (265)
receptor; Learning behavior (Wanibuchi, F. (265) 151)
107)
Muscarinic M, receptor
Di. = .
Muscarinic acetylcholine receptor agonist; YM796; Muscarinic M, :
Vas deferens, rat; a,-Adrenoceptor; N-Ethyl-maleimide; EEDQ
receptor; Learning behavior (Wanibuchi, F. (265) 151)
(N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline) (Browne, I. (265)
125)
Myosin light chain phosphorylation
a@,-Adrenoceptor; Thoracic aorta; B-Escin-skinned fiber (Satoh, M.
Phosphodiesterase inhibitor
(265) 133)
Blood vessel; Pimobendan; Milrinone; UD-CG 212 (Fujimoto, S.
(265) 159)
NANC (non-adrenergic non-cholinergic) transmission
Nitric oxide (NO); Electrical field stimulation; Nicotinic receptor;
Pimobendan
lleocecal sphincter; (Cat) (Mizhorkova, Z. (265) 77)
Blood vessel; Phosphodiesterase inhibitor; Milrinone; UD-CG 212
(Fujimoto, S. (265) 159)
Neostigmine
SK&F 96365; Endplate potential; Nicotinic acetylcholine receptor; Prostate, human
Receptor desensitisation (Hong, S.J. (265) 35) a,-Adrenoceptor subtype; Chloroethylclonidine; Nifedipine; Vas def-
erens, rat; Spleen, rat (Teng, C.-M. (265) 61)
Neuropeptide Y
Benextramine; Nonpeptide antagonist; Neuropeptide Y receptor Protein kinase C
subtype; Binding affinity (Melchiorre, C. (265) 93) Acetyl-L-carnitine; Behavior; (Rat) (Pascale, A. (265) 1)
Megestrol acetate; Appetite; Cancer anorexia; Cachexia; Hypothala- QT duration
mus (McCarthy, H.D. (265) 99) Mexiletine; Dofetilide; Conduction; Action potential duration;
(Guinea-pig); (In vivo) (Todt, H. (265) 43)
Neuropeptide Y receptor subtype
Neuropeptide Y; Benextramine; Nonpeptide antagonist; Binding Receptor
affinity (Melchiorre, C. (265) 93) Dopamine; Electrophysiology; d-Amphetamine; Antipsychotic; (Rat)
(Shepard, P.D. (265) 141)
Nicotinic acetylcholine receptor
SK&F 96365; Neostigmine; Endplate potential; Receptor desensiti- desensitisation
sation (Hong, S.J. (265) 35) SK&F 96365; Neostigmine; Endplate potential; Nicotinic acetyl-
choline receptor (Hong, S.J. (265) 35)
Key word ind/ Eeuroxpea n Journal of Pharmacology 265 (1994) 191-195
Ropinirole Thoracic aorta
Dopamine; D,-like receptor; Spontaneously hypertensive rat (SHR); a,-Adrenocentor; $-Escin-skinned fiber; Myosin light chain
Cardiovascular; Tolerance; (Monkey) (Parker, $.G. (265) 17) phosphorylation (Satoh, M. (265) 133)
Selective breeding Tolerance
Analgesia; Morphine; Tail flick assay; Tolerance (Lutfy, K. (265) 171) Ropinirole; Dopamine; D,-like receptor; Spontaneously hypertensive
rat (SHR), Cardiovascular; (Monkey) (Parker, $.G. (265) 17)
SK&F 96365
Analgesia; Morphine; Selective breeding; Tail flick assay (Lutfy, K.
Neostigmine; Endplate potential; Nicotinic acetylcholine receptor;
(265) 171)
Receptor desensitisation (Hong, S.J. (265) 35)
UD-CG 212
SK-N-MC cell Blood vessel; Phosphodiesterase inhibitor; Pimobendan; Milrinone
aCGRP (calcitonin-gene related peptide), human; aCGRP-(8-—37), (Fujimoto, S. (265) 159)
human; BCGRP-~8-37), human; Vas deferens, rat; Atrium, guinea-
pig (Longmore, J. (265) 53) Vascular tone
Interleukin-18 ; Endothelium; cGMP (Schini-Kerth, V. (265) 83)
Smooth muscle, airway
Vas deferens, rat
Muscarinic receptor; Bronchodilator agent; Allergy and immunology;
aCGRP (calcitonin-gene related peptide), human; aCGRP-8-37),
(Guinea pig) (Howell, R.E. (265) 67)
human; BCGRP-~8-37), human; Atrium, guinea-pig; SK-N-MC cell
(Longmore, J. (265) 53)
Spleen, rat
a,-Adrenoceptor subtype; Chloroethylclonidine; Nifedipine; Vas def- a,-Adrenoceptor subtype; Chloroethyliclonidine; Nifedipine; Spleen,
erens, rat; Prostate, human (Teng, C.-M. (265) 61) rat; Prostate, human (Teng, C.-M. (265) 61)
Spontaneously hypertensive rat (SHR) a,-Adrenoceptor, N-Ethyl-maleimide; Phenoxybenzamine; EEDQ
Ropinirole; Dopamine; D,-like receptor; Cardiovascular, Tolerance; ( N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline) (Browne, 1. (265)
(Monkey) (Parker, $.G. (265) 17) 125)
Vasodilation
Tachykinin NK, receptor
Lipoprotein; Nitric oxide (NO); Endothelium (Galle, J. (265) 111)
Chromodacryorrhea; Foot tapping; CNS (central nervous system)
penetration; (Gerbil) (Rupniak, N.M.J. (265) 179) YM796
Muscarinic acetylcholine receptor agonist; Muscarinic M, receptor;
Tail flick assay Muscarinic M, receptor; Learning behavior (Wanibuchi, F. (265)
Analgesia; Morphine; Selective breeding; Tolerance (Lutfy, K. (265) 151)
171)